Tempest in the Melting Pot: Genomics Reimbursement in 2012

Foley Hoag LLP
Contact

In This Issue:

Introduction; The World of Yesterday; Cracks in the System Widen; A Rumble on the Mountain - 1. Reimbursement for genetic laboratory tests and 2. Handling of high-value genomic tests; What May Happen Next - 1. Will genomic tests move to the physician fee schedule? No. and 2. Will CMS use the new genetic codes in 2012? No. and 3. Will the AMA Coding Process Consider IVDMIAs? Uncertain.

Introduction

The core set of genetic test codes used by U.S. insurers and Medicare date to 1993. Only general information is conveyed by these codes to insurers – “DNA probe x 2.” They lead to payment for genetic tests based on a fixed price per genetic test step (such as “DNA probe x 2” or “DNA amplification x 3”). The payment was set using rules for the Medicare clinical laboratory fee schedule, rules which date to 1984.

Please see full issue below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Foley Hoag LLP | Attorney Advertising

Written by:

Foley Hoag LLP
Contact
more
less

Foley Hoag LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.